470 related articles for article (PubMed ID: 6984337)
1. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
2. Characteristic immunological responses to an experimental mouse brain tumor.
Yamasaki T; Handa H; Yamashita J; Namba Y; Hanaoka M
Cancer Res; 1983 Oct; 43(10):4610-7. PubMed ID: 6603902
[TBL] [Abstract][Full Text] [Related]
3. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
[TBL] [Abstract][Full Text] [Related]
4. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806
[TBL] [Abstract][Full Text] [Related]
5. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory effects of interleukin 2 and interferon on syngeneic murine malignant glioma-specific cytotoxic T-lymphocytes.
Yamasaki T; Kikuchi H; Yamashita J; Handa H; Kuwata S; Taguchi M; Namba Y; Hanaoka M
Cancer Res; 1988 Jun; 48(11):2981-7. PubMed ID: 3259157
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
Lee FH; Currie D; Hwang KM
Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
11. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No To Shinkei; 1982 Apr; 34(4):393-8. PubMed ID: 7093076
[TBL] [Abstract][Full Text] [Related]
12. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
Yamamoto H; Takata M; Fujimoto S
Jpn J Cancer Res; 1987 Feb; 78(2):176-84. PubMed ID: 2951356
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of T lymphocyte subsets in antiviral host defense.
Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
[TBL] [Abstract][Full Text] [Related]
14. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
15. Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas.
Yamasaki T; Handa H; Yamashita J; Namba Y; Hanaoka M
J Neurooncol; 1986; 3(4):353-62. PubMed ID: 2937888
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
[TBL] [Abstract][Full Text] [Related]
17. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
Plautz GE; Touhalisky JE; Shu S
Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
[TBL] [Abstract][Full Text] [Related]
18. Induction of "innocent bystander" cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt-1+2- mammary tumor immune T-cells.
Paul RD; Lopez DM
Cancer Res; 1987 Feb; 47(4):1105-10. PubMed ID: 2879623
[TBL] [Abstract][Full Text] [Related]
19. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
Sobotková E; Nouza K
Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
